PL-AC-343

N/A

Report date: 2023/09/25 13:52:21
NME

Base Information

Drug NamePL-AC-343
Drug Alias NamePL-AC-343
ClassificationSmall molecules
Mechanisms of ActionBradykinin receptors antagonists
TargetsBradykinin receptors
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPle Pharmacy (Jiangsu) Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A